ACell To Pay $15M To Settle Recall, False-Claims Allegations
Wound-care products manufacturer ACell Inc. has agreed to pay $15m to settle charges related to its MicroMatrix product. The company reportedly encouraged false claims to be filed and staged a recall of contaminated devices without alerting the FDA.
You may also be interested in...
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.
Pear Therapeutics’ Somryst insomnia treatment tool has become the first FDA-cleared product that was reviewed through the agency’s Software Precertification Pilot Program.
The US agency is relaxing some regulatory requirements on facial masks and actively pursuing ways to reprocess N95 respirators used by medical staff under an immediately-in-effect guidance document.